Contact Us
Subscribe
E-Edition

38°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
Sports
Obits
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Subscribe
Archives
Best of 2025
Pet Contest

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Psyched Wellness Ltd (OP:PSYCF)

0.0130 +0.0011 (+9.24%)

Streaming Delayed Price Updated: 11:31 AM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Psyched Wellness Ltd

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More ↗

September 05, 2023

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

Via Benzinga

EXCLUSIVE: Psychedelics Co. Closes $7.5M Financing - Here's Its Secret To Raising Millions In A Tough Environment ↗

September 01, 2023

In the bustling heart of Miami, amidst the buzz of the Benzinga Cannabis and Psychedelics Capital Conference, a pivotal conversation ignited a partnership destined to revolutionize the world of...

Via Benzinga

Topics Cannabis

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗

May 15, 2023

Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths...

Via Benzinga

Amanita Muscaria Mushrooms Are Taking The Lead In Markets As Research Ramps Up ↗

May 04, 2023

Amanita Muscaria is the only kind of mushroom currently legal. As its health benefits are regularly being confirmed in studies, demand for related products is rapidly growing.

Via Benzinga

Amanita Muscaria: A Legal Psychoactive Mushroom With Potential Therapeutic Effects ↗

April 22, 2021

Amanita Muscaria is an understudied species of psychoactive mushroom that’s as commonplace as it is misunderstood. The iconic red-c...

Via Benzinga

Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation ↗

February 16, 2023

Delix Nabs 2 New Partners Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience. The goal is to expedite Delix's drug...

Via Benzinga

Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce ↗

January 24, 2023

Health Canada Oks Clinical-Grade MDMA Export To UK Life sciences psychedelics company PharmAla Biotech Holdings Inc. and its manufacturing partners received a Health Canada export permit for no less...

Via Benzinga

Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States ↗

November 03, 2022

Canadian-based producer of mushroom-derived health supplements Psyched Wellness Ltd.

Via Benzinga

Amanita Muscaria Mushroom-Based Products Now Offered Online By Psyched Wellness ↗

June 15, 2022

Canadian life sciences company Psyched Wellness Ltd.

Via Benzinga

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...

Via Benzinga

Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage ↗

April 25, 2022

Via Benzinga

EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle ↗

April 19, 2022

Psyched Wellness Ltd (OTCQB: PSYCF) plans to begin selling a psychoactive mushroom extract this summer that’s never been scheduled as a drug in the U.S.

Via Benzinga

Psyched Wellness CEO Buys This Many Shares In The Open Market ↗

April 19, 2022

Jeffrey Stevens, the CEO and co-founder of Psyched Wellness (OTCQB: PSYCF), has bought 321,000 shares of the company in the open market at CA$0.125 per share for a total cost of of CA$40,125 (around...

Via Benzinga

Core One Labs Begins Trading On OTCQB ↗

April 06, 2022

Under the CLABF symbol, psychedelics-oriented company Core One Labs (OTCQB: CLABF) started trading on the OTCQB Venture ...

Via Benzinga

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗

October 18, 2021

The Week In Psychedelics

Via Benzinga

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗

October 13, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

starkvilledailynews.com
304 E. Lampkin Street,
Starkville, MS 39759
Phone: 662-323-1642
Email: editor@starkvilledailynews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Psyched Wellness Ltd (OP:PSYCF)

Headline News about Psyched Wellness Ltd

Sections

Services

Follow Us